An historical CIOMS report covering the CIOMS Pilot Project on International Reporting of Adverse Drug Reactions aimed at developing internationally acceptable reporting methods whereby manufacturers can report postmarketing adverse drug reactions rapidly, efficiently and effectively to regulators.